Palmucci, Carla

Abstract Background: Perineural invasion (PNI) is a key prognostic factor in oral squamous cell carcinoma (OSCC). Recent studies have proposed the importance of subcategorizing PNI based on location in relation to the tumor. However, current gaps in definition of PNI subcategories limit its integration into staging system and treatment planning. This study evaluates the prognostic value of the presence of PNI and its location, in correlation with other tumor characteristics, and examines their relationship with survival and recurrence. Design: A total of 159 patients with histologically confirmed OSCC from February 2022–May 2025 were included in the study. PNI was subclassified into intratumoral, peripheral and extratumoral. Association of PNI metrics with other prognostic factors (margin status, lymph node metastasis [LN mets], and lymphovascular invasion [LVI]) were assessed using a Fisher’s exact test (categorical variables). Comparisons of disease-free survival (DFS) and overall survival (OS) between the PNI subgroups were made with a logrank test. Cox proportional hazards regression models were used to find univariate predictors of death and the composite outcome of recurrence or death. A p value <0.05 was considered statistically significant. Statistical analyses were performed using R Statistical Software (version 4.4.1; R Foundation for Statistical Computing, Vienna, Austria). Results: 49/159 cases were PNI positive. Median age: 69 years and male predominance (58.5%). Floor of mouth was the most common site. Presence of PNI correlated significantly with positive margins and positive LVI (p = 0.013 and 0.048 respectively). However, only peripheral PNI showed significant correlation with LN mets (p = 0.004). On univariate analysis, the strongest predictors of recurrence or death were larger tumor size (p <0.001); presence of PNI (p = 0.014), especially intratumoral (p = 0.003); positive LN mets (p = 0.024); and non-white race (p = 0.023). Both DFS and OS were significantly worse in patients with PNI compared with those without (DFS: p = 0.012, OS: p = 0.018). Subclassification of PNI showed a significantly poorer DFS and OS in cases with intratumoral PNI (DFS: p = 0.002, OS: p = 0.012), but not with extratumoral or peripheral PNI.

Abstract Objective Using a US Food and Drug Administration (FDA) emergency use authorization (EUA) reverse transcription polymerase chain reaction (RT-PCR) method, we examined the analytic performance accuracy of saliva specimens as compared to nasopharyngeal (NP) specimens in symptomatic patients. Correlation between test results and symptoms was also evaluated. Methods Over a 5-week period in 2020, 89 matched saliva and nasopharyngeal swabs were collected from individuals exhibiting symptoms consistent with SARS-CoV-2. Specimens were tested with an FDA EUA-approved RT-PCR method, and performance characteristics were compared. Results The concordance rate between saliva and nasopharyngeal testing was 93.26%. The mean cycle threshold value of saliva when compared to the NP specimen was 3.56 cycles higher. As compared to NP swab, saliva testing demonstrates acceptable agreement but lower sensitivity. Conclusion When compared to a reference method using NP swabs, the use of saliva testing proved to be a reliable method. Self-collected saliva testing for SARS-CoV-2 allows for a viable option when trained staff or collection materials are in short supply.

AbstractIntroductionRadiologically inserted gastrostomy (RIG) placement in patients with amyotrophic lateral sclerosis (ALS) carries risks related to periprocedural sedation and analgesia. To minimize these risks, we used a paravertebral block (PVB) technique for RIG placement.MethodsWe retrospectively reviewed patients with ALS undergoing RIG placement under PVB between 2013 and 2017.ResultsNinety‐nine patients with ALS underwent RIG placement under PVB. Median (range) age was 66 (28 to 86) years, ALS Functional Rating Scale—Revised score was 27 (6 to 45), and forced vital capacity was 47% (8%–79%) at time of RIG placement. Eighty‐five (85.9%) patients underwent RIG placement as outpatients, with a mean postanesthesia care unit stay of 2.3 hours. The readmission rate was 4% at both 1 and 30 days postprocedure.DiscussionPVB for RIG placement has a low rate of adverse events and provides effective periprocedural analgesia in patients with ALS, the majority of whom can be treated as outpatients.

Poly(GP) proteins are a promising pharmacodynamic marker for developing and testing therapeutics for treating C9ORF72 -associated amyotrophic lateral sclerosis.